National Comprehensive Cancer Network

NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN Drug and Biologics Compendium - Panel Members

Professionals


Go back to previous page

 

 

   
 

NCCN Drugs & Biologics Compendium

NCCN Acute Myeloid Leukemia (AML) Panel Members

These chapters of the NCCN Drugs & Biologics Compendium™ were developed directly from the NCCN Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia (AML).

These guidelines were developed by the following NCCN Acute Myeloid Leukemia (AML) Panel Members.

Margaret R. O'Donnell, MD/Chair
City of Hope Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

Camille N. Abboud, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Acute Myeloid Leukemia (AML)

Jessica Altman, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Acute Myeloid Leukemia (AML)

Frederick R. Appelbaum, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Acute Myeloid Leukemia (AML)

Daniel A. Arber, MD
Stanford Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

Steven E. Coutre, MD
Stanford Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

Lloyd E. Damon, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

James Foran, MD
University of Alabama at Birmingham Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

Salil Goorha, MD
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute
Acute Myeloid Leukemia (AML)

Jeffrey Lancet, MD
H. Lee Moffitt Cancer Center & Research Institute
Acute Myeloid Leukemia (AML)

Lori J. Maness, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center
Acute Myeloid Leukemia (AML)

Guido Marcucci, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
Acute Myeloid Leukemia (AML)

Peter G. Maslak, MD
Memorial Sloan-Kettering Cancer Center
Acute Myeloid Leukemia (AML)

Michael Millenson, MD
Fox Chase Cancer Center
Acute Myeloid Leukemia (AML)

Joseph O. Moore, MD
Duke Comprehensive Cancer Center
Acute Myeloid Leukemia (AML)

 
 
 

Farhad Ravandi, MD
The University of Texas MD Anderson Cancer Center
Acute Myeloid Leukemia (AML)

Paul Shami, MD
Huntsman Cancer Institute at the University of Utah
Acute Myeloid Leukemia (AML)

B. Douglas Smith, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Acute Myeloid Leukemia (AML)

Richard M. Stone, MD
Dana-Farber/Brigham and Women's Cancer Center
Acute Myeloid Leukemia (AML)

Stephen Strickland, MD
Vanderbilt-Ingram Cancer Center
Acute Myeloid Leukemia (AML)

Martin S. Tallman, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Acute Myeloid Leukemia (AML)

Eunice Wang, MD
Roswell Park Cancer Institute
Acute Myeloid Leukemia (AML)

 
 
 

Disclosures for the NCCN Acute Myeloid Leukemia (AML) Guidelines Panel